
    
      The purpose of this trial is to determine if administration of denufosol is well-tolerated
      and more efficacious than placebo in stimulating subretinal fluid reabsorption and retinal
      reattachment without surgical intervention in subjects presenting with rhegmatogenous retinal
      detachment.
    
  